Research graph
References from Reduced menopausal symptom severity in women with epilepsy: a multicenter case-control study. Local targets link to admitted publications; unresolved targets remain external evidence.
Duration of menopausal vasomotor symptoms over menopause transition
10.1001/jamainternmed.2014.8063 · 2015 · External reference
Consesnsus statement for non-hormonal-based treatments for menopausal symptoms
10.1177/2053369117711646 · 2017 · External reference
on behalf of the AACE Reproductive Endocrinology scientific Committee. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on menopause-2017 update
10.4158/ep171828.ps · 2017 · External reference
Gabapentin for hot flashes in 420 women with breast cancer: a double-blind plasebo controlled trial
10.1016/s0140-6736(05)67215-7 · 2005 · External reference
Gabapentin’s effects on hot flashes in postmenopausal women: a randomized controlled trial
2003 · External reference
Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial
2008 · External reference
Hot flashes refractory to HRT and SSRI but responsive to gabapentin therapy
10.1016/j.jpainsymman.2003.07.007 · 2004 · External reference
Gabapentin, estrogen, and plasebo for treating hor flashes: a randomized controlled trial
10.1097/01.aog.0000222383.43913.ed · 2006 · External reference
Phase III, randomized, double-blind, plasebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1
10.1200/jco.2009.24.5647 · 2010 · External reference
Executive summary: Stages of reproductive aging workshop (STRAW)
10.1016/s0015-0282(01)02909-0 · 2001 · External reference
The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints
10.3109/13697130009167600 · 2000 · External reference
The reliability and validity of the Turkish version of the Menopause Symptom Rating Scale
2005 · External reference
The pathophysiology and therapy of menopausal symptoms
10.1016/j.ogrm.2020.03.005 · 2000 · External reference
A new hope for woman with vasomotor symptoms: Neurokinin B Antagonists
10.3390/jcm14051438 · 2025 · External reference
10.1002/ajhb.1077
10.1002/ajhb.1077 · External reference
Advances in pharmacotherapy for menopausal vasomotor symptoms
10.1007/s40265-025-02231-8 · 2025 · External reference
The menopause transition and women's health at midlife: a progress report from the Study of Women's Health across the Nation (SWAN)
10.1097/gme.0000000000001424 · 2019 · External reference
Long-term prognosis of seizures with onset in childhood
10.1056/nejm199806113382402 · 1998 · External reference
Long-term employment, education, and healthcare costs of childhood and adolescent onset of epilepsy
2021 · External reference
Metabolic syndrome in people with epilepsy
10.1016/j.yebeh.2020.106992 · 2020 · External reference
Menopausal symptoms and cardiometabolic risk factors in middle-aged women: a cross-sectional and longitudinal study with 4-year follow-up
10.1016/j.maturitas.2023.05.004 · 2023 · External reference
The need to do better-are we still letting our patients down and at what cost?
10.1177/2053369115586122 · 2015 · External reference
